journal article·2026

Bone marrow mesenchymal stem cells overexpressing FGF-2 loaded onto a decellularized extracellular matrix hydrogel for the treatment of osteoarthritis

Yue Qiu, Bo Yu, Cancai Jiang, Huangyi Yin, Jinzhi Meng, Hongtao Wang, Lingyun Chen, Yang Cai, Tianyu Ren, Qingfa Qin, Jia Li, Jun Yao

Biomaterials Science· Volume 14· Issue 1
Publisher page

Abstract

Osteoarthritis, as one of the major disabling diseases in the elderly, has a long-term impact on patients' quality of life and brings heavy medical and social burden. The pathogenesis of osteoarthritis is still unclear, and the main pathological changes include chondrocyte death and osteochondral damage. Therefore, how to solve the cartilage damage caused by osteoarthritis has become the key and difficult point in the clinical treatment of osteoarthritis. Bone marrow mesenchymal stem cells (MSCs) have the potential for self-renewal and multidirectional differentiation, and their engineering has been a hot research topic for the treatment of cartilage damage in recent years. In this study, an injectable hydrogel with stable and continuous release of growth factors was successfully prepared by modifying bone marrow mesenchymal stem cells to overexpress fibroblast growth factor-2 (FGF-2) and piggybacking on a decellularized extracellular matrix (dECM) hydrogel for the repair of cartilage injury in osteoarthritis. This hydrogel demonstrated excellent biocompatibility both in vitro and in vivo. In 3D cell culture, BMSCs in the dECM hydrogel survived, proliferated, and produced abundant cartilage-specific extracellular matrix and growth factors, promoting BMSC differentiation into hyaline chondrocytes. In vitro and in vivo experiments, along with RNA-seq analysis, showed that engineered BMSCs loaded onto the dECM hydrogel could inhibit chondrocyte apoptosis and boost BMSC differentiation. In summary, dECM hydrogels carrying FGF-2 overexpressing bone marrow mesenchymal stem cells have great prospects in accelerating osteochondral defect repair and delaying the progression of osteoarthritis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · Osteoarthritis Treatment and Mechanisms · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bone and Joint Surgery, The First Affiliated Hospital, of Guangxi Medical University, Nanning, 530021, China

Geriatric Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China

Department of Orthopedics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China

Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China

Guangxi Key Laboratory of Regenerative Medicine, International Joint Laboratory on Regeneration of Bone and Soft Tissue, Nanning, 530021, China

Funding

Scientific Research and Technology Development Program of Guangxi

References (42)

Show source-provided references
1. Hoy · Ann. Rheum. Dis. · 2015 · 74 · 410.1136/annrheumdis-2014-205393 ↗
2. Silverwood · Osteoarthritis Cartilage · 2015 · 23 · 50710.1016/j.joca.2014.11.019 ↗
3. Hoshi · Histochem. Cell Biol. · 2018 · 149 · 37510.1007/s00418-018-1652-2 ↗
4. Ding · Curr. Stem Cell Res. Ther. · 2021 · 16 · 84010.2174/1574888x16666210127130044 ↗
5. Whitney · Ann. N. Y. Acad. Sci. · 2017 · 1410 · 2610.1111/nyas.13554 ↗
6. Demoor · Biochim. Biophys. Acta · 2014 · 1840 · 241410.1016/j.bbagen.2014.02.030 ↗
7. Wang · Sci. China: Life Sci. · 2014 · 57 · 58610.1007/s11427-014-4673-7 ↗
8. Odabas · Methods Mol. Biol. · 2014 · 1109 · 4710.1007/978-1-4614-9437-9_3 ↗
9. Filardo · Knee Surg. Sports Traumatol. Arthrosc. · 2013 · 21 · 171710.1007/s00167-012-2329-3 ↗
10. Zeng · npj Regener. Med. · 2022 · 7 · 7510.1038/s41536-022-00269-w ↗
11. Chan · Acta Biomater. · 2013 · 9 · 526210.1016/j.actbio.2012.09.005 ↗
12. Fiordalisi · Trends Biotechnol. · 2020 · 38 · 94710.1016/j.tibtech.2020.05.002 ↗
13. Mercuri · Tissue Eng., Part A · 2013 · 19 · 95210.1089/ten.TEA.2012.0088 ↗
14. Beck · Acta Biomater. · 2016 · 38 · 9410.1016/j.actbio.2016.04.019 ↗
15. Saldin · Acta Biomater. · 2017 · 49 · 110.1016/j.actbio.2016.11.068 ↗
16. Utomo · Int. J. Biomater. · 2019 · 2019 · 835687210.1155/2019/8356872 ↗
17. Li · Mater. Sci. Eng., C · 2019 · 105 · 11013910.1016/j.msec.2019.110139 ↗
18. Perrimon · Nature · 2000 · 404 · 72510.1038/35008000 ↗
19. Itoh · Trends Genet. · 2004 · 20 · 56310.1016/j.tig.2004.08.007 ↗
20. Zhang · Regener. Med. · 2020 · 15 · 212910.2217/rme-2019-0080 ↗
21. S. L.Woo and J. A.Buckwalter . AAOS/NIH/ORS workshop. Injury and repair of the musculoskeletal soft tissues. Savannah, Georgia, June 18–20, 1987. J. Orthop. Res. 1988;6(6):907–931. 10.1002/jor.110006061510.1002/jor.1100060615 ↗
22. Rothrauff · Organogenesis · 2014 · 10 · 1310.4161/org.27404 ↗
23. Cooper · J. Bone Jt. Surg., Am. Vol. · 1970 · 52 · 110.2106/00004623-197052010-00001 ↗
24. Brown · Biomaterials · 2022 · 289 · 12178610.1016/j.biomaterials.2022.121786 ↗
25. Yang · Biomaterials · 2008 · 29 · 237810.1016/j.biomaterials.2008.01.037 ↗
26. Zhong · Bioact. Mater. · 2020 · 5 · 87110.1016/j.bioactmat.2020.06.008 ↗
27. Meng · Front. Immunol. · 2022 · 13 · 107252610.3389/fimmu.2022.1072526 ↗
28. Wei · ACS Appl. Mater. Interfaces · 2021 · 13 · 5480110.1021/acsami.1c17629 ↗
29. Aigner · Arthritis Rheum. · 2001 · 44 · 130410.1002/1529-0131(200106) ↗
30. Héraud · Ann. Rheum. Dis. · 2000 · 59 · 95910.1136/ard.59.12.959 ↗
31. Galipeau · Cell Stem Cell · 2018 · 22 · 82410.1016/j.stem.2018.05.004 ↗
32. Desgres · Cell Stem Cell · 2019 · 25 · 59410.1016/j.stem.2019.10.001 ↗
33. Wang · Mater. Today Bio · 2023 · 18 · 10053010.1016/j.mtbio.2022.100530 ↗
34. Ghobrial · CA Cancer J. Clin. · 2005 · 55 · 17810.3322/canjclin.55.3.178 ↗
35. Jin · J. Cell. Mol. Med. · 2021 · 25 · 928110.1111/jcmm.16860 ↗
36. Liu · Cell Cycle · 2018 · 17 · 241110.1080/15384101.2018.1526603 ↗
37. Mobasheri · Nat. Rev. Rheumatol. · 2017 · 13 · 30210.1038/nrrheum.2017.50 ↗
38. Cannata · Diabetes/Metab. Res. Rev. · 2020 · 36 · e325410.1002/dmrr.3254 ↗
39. Wang · Cell Death Dis. · 2021 · 12 · 50610.1038/s41419-021-03791-9 ↗
40. Mankin · J. Bone Jt. Surg., Am. Vol. · 1971 · 53 · 52310.2106/00004623-197153030-00009 ↗
41. Nakagawa · J. Orthop. Res. · 2010 · 28 · 15610.1002/jor.20976 ↗
42. Iwasa · J. Orthop. Res. · 2014 · 32 · 23110.1002/jor.22506 ↗